PTPRN
PTPRN (protein tyrosine phosphatase receptor type N, also known as IA-2 or ICA512) is a receptor-type member of the protein tyrosine phosphatase family. It regulates insulin secretory granule dynamics and insulin gene expression in pancreatic beta-cells, and it is an autoantigen in diabetes mellitus. Browse Assay Genie's current range of PTPRN research reagents below, or read on for the biology behind the target.
PTPRN acts in pancreatic beta-cells through cleaved forms of its intracellular region. The fragment known as ICA512-CCF, when translocated to the nucleus, promotes expression of insulin and other granule-related genes. This involves binding to and regulating STAT5B, probably by preventing its dephosphorylation and potentially by inducing its sumoylation through recruitment of PIAS4. In this way it enhances beta-cell proliferation, converging with STAT5B and STAT3 signalling. In the cytoplasm, ICA512-CCF regulates the dynamics and exocytosis of insulin secretory granules. It does so by dimerising with ICA512-TMF and displacing SNTB2, which increases granule mobility and exocytosis.
The PTPRN gene encodes a member of the protein tyrosine phosphatase (PTP) family, which belongs to the receptor class 8 subfamily. PTPs are signalling molecules that regulate cell growth, differentiation, the mitotic cycle and oncogenic transformation. The PTPRN protein has an extracellular region, a single transmembrane region and a single catalytic domain, which defines it as a receptor-type PTP. UniProt records its locations as membrane, secretory vesicle membrane, perikaryon, axon, synapse, cell membrane, endosome and nucleus. Alternate splicing produces multiple transcript variants. The mouse and rat orthologs are both named Ptprn.
PTPRN is also known as IA-2 and ICA512. The IA-2 name reflects its identification as an autoantigen reactive with sera from patients with insulin-dependent diabetes mellitus, and it may be a target of autoimmunity in diabetes mellitus. HGNC places the gene in the receptor-type protein tyrosine phosphatase group and among microRNA protein-coding host genes. Researchers studying beta-cell biology and autoimmunity use PTPRN antibody, PTPRN ELISA kit and PTPRN protein reagents to investigate the protein.
ICA512-CCF regulates the mobility and exocytosis of insulin secretory granules by dimerising with ICA512-TMF and displacing SNTB2.
Nuclear ICA512-CCF converges with STAT5B and STAT3 signalling to enhance pancreatic beta-cell proliferation and promote insulin gene expression.
PTPRN, as IA-2, is an autoantigen reactive with insulin-dependent diabetes mellitus patient sera and a potential target of autoimmunity.
As a receptor-type PTP, PTPRN belongs to a family regulating cell growth, differentiation, mitotic cycle and oncogenic transformation.
PTPRN is a receptor-type protein tyrosine phosphatase family member. Its cleaved fragment ICA512-CCF promotes insulin and granule-related gene expression by regulating STAT5B, and in the cytoplasm it regulates insulin secretory granule mobility and exocytosis. It also enhances pancreatic beta-cell proliferation.
PTPRN is also called IA-2 and ICA512. The UniProt name is receptor-type tyrosine-protein phosphatase-like N, and HGNC lists it as protein tyrosine phosphatase receptor type N. Alternate splicing gives multiple transcript variants. Check the datasheet of any product for its validated reactivity.
PTPRN was found to be an autoantigen reactive with sera from insulin-dependent diabetes mellitus patients, so it may be a target of autoimmunity in diabetes mellitus. Mouse and rat both carry a Ptprn ortholog, which allows comparative work in those species.
Other protein tyrosine phosphatases, STAT signalling proteins and insulin secretion pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16849; product specifications from Assay Genie datasheets.